Denali Therapeutics Inc (DNLI)
24.26
-0.16
(-0.68%)
USD |
NASDAQ |
Nov 21, 16:00
24.26
0.00 (0.00%)
After-Hours: 18:57
Denali Therapeutics Market Cap: 3.491B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.515B |
| November 19, 2024 | 3.503B |
| November 18, 2024 | 3.480B |
| November 15, 2024 | 3.605B |
| November 14, 2024 | 4.095B |
| November 13, 2024 | 4.264B |
| November 12, 2024 | 4.302B |
| November 11, 2024 | 4.545B |
| November 08, 2024 | 4.512B |
| November 07, 2024 | 4.260B |
| November 06, 2024 | 4.253B |
| November 05, 2024 | 3.979B |
| November 04, 2024 | 3.916B |
| November 01, 2024 | 3.893B |
| October 31, 2024 | 3.736B |
| October 30, 2024 | 3.864B |
| October 29, 2024 | 3.951B |
| October 28, 2024 | 3.996B |
| October 25, 2024 | 3.761B |
| October 24, 2024 | 3.803B |
| October 23, 2024 | 3.751B |
| October 22, 2024 | 3.782B |
| October 21, 2024 | 3.794B |
| October 18, 2024 | 3.969B |
| October 17, 2024 | 3.944B |
| Date | Value |
|---|---|
| October 16, 2024 | 3.979B |
| October 15, 2024 | 3.862B |
| October 14, 2024 | 3.859B |
| October 11, 2024 | 4.028B |
| October 10, 2024 | 3.702B |
| October 09, 2024 | 3.815B |
| October 08, 2024 | 3.845B |
| October 07, 2024 | 3.826B |
| October 04, 2024 | 4.118B |
| October 03, 2024 | 4.059B |
| October 02, 2024 | 4.176B |
| October 01, 2024 | 4.124B |
| September 30, 2024 | 4.190B |
| September 27, 2024 | 4.213B |
| September 26, 2024 | 4.190B |
| September 25, 2024 | 4.152B |
| September 24, 2024 | 4.341B |
| September 23, 2024 | 4.329B |
| September 20, 2024 | 4.425B |
| September 19, 2024 | 4.445B |
| September 18, 2024 | 4.404B |
| September 17, 2024 | 4.392B |
| September 16, 2024 | 4.342B |
| September 13, 2024 | 4.405B |
| September 12, 2024 | 4.003B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.497B
Minimum
Mar 16 2020
11.22B
Maximum
Dec 22 2020
4.226B
Average
3.769B
Median
Nov 07 2022
Market Cap Benchmarks
| AIM ImmunoTech Inc | 13.47M |
| Perspective Therapeutics Inc | 202.09M |
| Protalix BioTherapeutics Inc | 122.97M |
| Electromed Inc | 235.72M |
| Armata Pharmaceuticals Inc | 75.98M |
Market Cap Related Metrics
| PS Ratio | 11.14 |
| Price to Book Value | 2.648 |
| Price | 24.26 |
| Earnings Yield | -11.38% |